Surviving Retirement
Followers
Friday, 1 September 2017
Novartis' CAR-T therapy, now approved, faces questions about price and side effects
The Swiss drugmaker is the first to receive FDA approval to market a CAR-T therapy.
from Most popular articles from Medical Marketing and Media http://ift.tt/2vIDsbX
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment